Explore more publications!

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on January 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead
OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters
Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences
SRx Health Solutions Invests in Common Stock of Opendoor Technologies
Clene to Present at the Emerging Growth Conference
Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
Elicio Therapeutics Reports Inducement Grants
Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions